![]() |
市场调查报告书
商品编码
1324867
胆红素测量仪器市场:现状分析与预测(2022-2028)Bilirubin Meter Market: Current Analysis and Forecast (2022-2028) |
胆红素测量仪器市场预计在预测期内将以 6% 的复合年增长率增长。识别新生儿黄疸的诊断工具。这是由于新生儿黄疸发生率增加,以及8週前出生的新生儿黄疸发生率增加所致。例如,根据《2022 年国家卫生服务报告》,妊娠 37 週之前的早产婴儿中,每 10 名就有 6 名出现黄疸,其中每 10 名婴儿就有 8 名出现黄疸。此外,与黄疸发生相关的危险因素包括器械助产、催产素引产、婴儿破裂和其他医疗状况。因此,所有这些因素预计将在预测期内推动市场增长。
按产品分,市场分为便携式胆红素计和台式胆红素计。其中,便携式胆红素测量设备预计在预测期内将以显着的复合年增长率增长。便携式胆红素测量仪通常体积小、重量轻,因此易于携带并在各种环境中使用,包括医院、诊所和家庭医疗保健。通常从指尖或脚后跟抽取少量血液,用于测量胆红素水平。因此,这一因素有助于该细分市场的增长。
按最终用户划分,市场分为医院、诊所和研究机构。其中,医院行业预计在预测期内将以较大的复合年增长率增长。医院在黄疸和肝炎等肝臟疾病的早期发现和治疗方面发挥着重要作用,有助于预防严重并发症。此外,优质医院拥有必要的医疗设备和人员,能够为多种病情的患者提供全面的护理,减轻医疗保健系统的整体负担。这些因素正在推动对医院的需求。
预计亚太地区在预测期内将以显着的复合年增长率增长。这是由于该地区医疗保健支出增加。例如,2021财年支付给医疗机构的医疗保健支出创下历史新高,达到316万亿美元,比上年增加14万亿美元(4.6%)。这正在推动该地区的市场增长。
Bilirubin meters are devices designed for the measurement of the concentration of bilirubin present in the blood or clinical specimen there are several types of bilirubin meters, including those that use spectroscopy, turbidity and impedance. The level of bilirubin should be interpreted in conjunction with other laboratory results and clinical findings. A high level of bilirubin can be a sign of a number of conditions including haemolytic anaemia, liver disease and neonatal jaundice. On the contrary, lower levels of bilirubin may be seen in patients taking antibiotics or may be due to other medical conditions including Gilbert's syndrome.
The bilirubin meter Market is anticipated to grow with a CAGR of 6% in the forecasted period. The diagnostic tools for the identification of neonatal jaundice. This is attributed to the rising incidence of jaundice amongst the neonates along with those neonates who are born before 8 weeks. For instance, according to the national health service 2022 report, around 6 out of 10 babies born develop jaundice including 8 out of 10 who are born prematurely before 37 weeks of pregnancy. Additionally, the risk factors associated with the development of jaundice include instrumental deliveries, induction of labour with oxytocin, infant bursting and other medical conditions. Thus, all these factors are anticipated to fuel the market growth in the forecast period.
Based on the product, the market is bifurcated into portable bilirubinometers and benchtop bilirubinometers. Amongst these, the portable bilirubinometer is anticipated to grow with a significant CAGR in the forecasted period. These are typically small and lightweight, making them easy to carry and use in a variety of settings, including hospitals, clinics, and home care settings. They use a small amount of blood, typically from a fingertip or heel stick, to measure the level of bilirubin. Thus, this factor is contributing towards the growth of this segment.
Based on end-users the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period. Hospitals play a crucial role in the early detection and management of liver disease, including jaundice and hepatitis which can help prevent severe complications of diseases. Additionally, hospitals are equipped with the necessary medical equipment and staff to provide comprehensive care to patients with a wide range of medical conditions and reduce the overall burden of the disease on the healthcare system. These elements are driving the demand for the hospitals
For a better understanding of the market adoption of the Behavior Health industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (UK, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Rest of World. Asia-pacific is anticipated to grow with a significant CAGR during the forecasted period. This is attributed to the increase in healthcare expenditure in this region. For instance, healthcare expenditures paid to medical institutions in fiscal 2021 reached a record USD 316 trillion, an increase of 14 trillion, or 4.6%, compared to the previous year. This is propelling the market growth in this region.
Some of the major players operating in the market include: Advanced Instruments Inc., APEL Co., Ltd., Siemens Medical Solutions USA, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Dragerwerk AG & Co. KGaA, Zhengzhou Dison Instrument and Meter Co., ltd. , Mennen Medical, Natus Medical Incorporated., DAVID, Micro Lab Instruments.